MedTrace Logo

Inpatient Cognitive-Behavioral Therapy to Reduce Suicide Risk Post-Discharge

NCT04168645 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 213

Last updated 2025-04-16

Study results available
· View outcomes & findings →

Summary

The goal of this randomized-controlled trial is to determine whether adding brief cognitive-behavioral therapy for suicide prevention (BCBT) to inpatient treatment improves suicide-related outcomes after the person leaves the hospital. The study will also determine whether being diagnosed with a substance use disorder impacts these outcomes. Participants will either receive treatment as usual or treatment as usual plus up to four sessions of BCBT during their inpatient stay. They will complete monthly follow-up assessments for six months after leaving the hospital.

Conditions

  • Suicide, Attempted

Interventions

BEHAVIORAL

Cognitive Behavioral Therapy

Up to 4 sessions of BCBT (depending on length of stay) will be provided. The first session lasts 1.5 hours and subsequent sessions are 1 hour.

Sponsors & Collaborators

  • American Foundation for Suicide Prevention

    collaborator OTHER

  • Hartford Hospital

    lead OTHER

Principal Investigators

  • David F Tolin, Ph.D. · Institute of Living/Hartford Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-20
Primary Completion
2023-08-15
Completion
2023-08-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04168645 on ClinicalTrials.gov